Medline Arterial Line Kit and IV Securement Set Recall
Areazine synthesizes this FDA recall directly from FDA's official public data feed. See our methodology for full source attribution and refresh cadence.
Medline Industries is recalling 250 kits containing lidocaine ampules due to quality issues identified during an FDA inspection of the ampule manufacturer.
What this FDA recall tells you, and what most readers miss
This notice was issued by FDA on August 8, 2026 and geographically references United States. Its severity classification of "medium" signals how the issuing agency weighs the risk of harm if no action is taken - "critical" and "high" tier alerts typically carry direct consumer actions, while "medium" and "low" tend toward informational guidance or monitoring advisories. The category it belongs to - FDA Recalls - determines the consumer-protection framework behind it, which shapes what remedies (refunds, replacements, repairs, or the recall itself) are available to affected consumers and which agency holds statutory responsibility for enforcement.
Most readers skim a notice like this, check whether they are personally affected, and move on. The more useful lens is to verify its scope, source, and timestamp, then compare related notices without assuming that one record proves a broader trend.
Areazine pairs this record with the original agency URL so you can check the primary source before acting. Its related labels are recall, product-safety, fda, Medical Devices.
What Happened
Medline Industries, LP is recalling certain convenience kits because they contain Huons Lidocaine HCL Injection USP 1% 10mg/ml 5mL Ampules subject to a separate recall by Huons Co., Ltd. for quality issues identified during a recent FDA manufacturing inspection.
Which Products Are Affected
- ARTERIAL LINE KIT, Model Number: ART890B, UDI-DI: 10653160360834 (each), 00653160360837 (case), Lot Number: 2025102390
- ULTRASOUND GUIDED IV SECUREMENT SET, Model Number: IVS3350, UDI-DI: 10653160313045 (each), 00653160313048 (case), Lot Number: 2025102490
250 kits distributed nationwide in the United States. Recall number Z-2543-2026. Classification: Class II. Recall initiated May 21, 2026.
What You Should Do
Consumers should follow instructions provided in the recalling firm's notification letter.
Why This Matters
The recall affects medical kits distributed across the United States that contain lidocaine ampules with identified quality issues.
Source
FDA recall Z-2543-2026 - Medline Industries, LP, Northfield, IL
Original source: FDA Official Notice ↗
Related FDA Recalls
All FDA Recalls →Nationwide notices with similar length or severity timing 8
Two Areazine-derived peer sets for this FDA recall: nearest notices by body length and by same severity near the same agency date. Peers come from other categories so they are not the same-feed Related list above.
Similar body length
Nearest notices by article body length (1,080 characters here).
Similar severity timing
Same severity (medium) notices issued closest in time to August 8, 2026.
Frequently Asked Questions
Common questions about this FDA recall.